Overall survival in advanced hepatocellular carcinoma treated with concomitant systemic therapy and stereotactic body radiation therapy or systemic therapy alone

Overview of attention for article published in Frontiers in oncology, November 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 21,067 followers.

RT @slusom: Congratulations to Alex Piening, Ph.D. on two recent publications. Read more here: https://t.co/Z8Ysjqps6f https://t.co/dEN3…

07 Jun 2024

Reply Repost Favourite

Congratulations to Alex Piening, Ph.D. on two recent publications. Read more here: https://t.co/Z8Ysjqps6f https://t.co/dEN3DYMPXS https://t.co/QWbCTHcqFT

06 Jun 2024

Reply Repost Favourite

RT @FrontOncology: New research: Overall survival in advanced hepatocellular carcinoma treated with concomitant systemic therapy and stereo…

27 Nov 2023

Reply Repost Favourite

New research: Overall survival in advanced hepatocellular carcinoma treated with concomitant systemic therapy and stereotactic body radiation therapy or systemic therapy alone: Introduction First-line systemic therapy (ST) options for advanced… https://t.

27 Nov 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.